News

Lighthouse Labs rebrands as Lighthouse Network, shifts focus to long-term founder development

Longtime Richmond accelerator Lighthouse Labs is rebranding to better reflect its commitment to startup founders.

The organization will now be known as Lighthouse Network and will make a “renewed focus” on long-term, human-centered development of founders, it said in its announcement.

“We’ve always believed that when founders thrive, so do their companies,” Debbie Irwin, who became the organization’s executive director in February 2024, said in a statement. “This transition to Lighthouse Network reflects what we’ve been doing for years — walking alongside founders, helping them navigate the messy middle and building the kind of trust and support systems that aren’t found in a typical accelerator.”

The changes include year-round founder support through mentorship, curated investor connections and targeted programming. That will include strategic events like its Founder Network Summit, Investor Connect and Demo Day. Lighthouse will host just one accelerator cohort per year, something it announced in February when it announced the program’s 18th cohort. It previously hosted two a year.

In the past, companies received $20,000 in equity-free financing for being selected to a cohort. But that ended this year, and it instead expanded what it calls “high-impact services” like fractional CFO support, mental health resources and deeper relationship building with investors.

Lighthouse said it will also work to grow a national network rooted in Richmond of founders, mentors and partners committed more to long-term success as opposed to short-term outcomes.

Along with the new name, the rebrand includes a new visual identity, messaging and website that Lighthouse says better reflects its broader vision and nationwide push.

“This isn’t just a name change,” Irwin said in a statement. “It’s a commitment to the people building bold ideas — and a recognition that founders need more than funding to succeed. They need community, connection and a place that sees them as humans first.”

Read more here.

Recent News

08/19/2026

ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance

ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza

08/18/2026

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients

08/14/2026

Transforming the finance function in life sciences: Empower scalable growth

Life sciences companies operate in one of the most complex business environments. Long R&D timelines, limited early-stage revenue, and dependence on external funding create a financial landscape where every decision carries strategic weight. In this context, finance is not a back-office function. It is an operational engine that drives whether a company survives, scales, or